VanEck Vectors Coal ETF KOL
94.92 USD 0.00 (+0.00%)
Dec 14, 2020, 3:59 PM EST
94.90 Day range 95.50
54.10 52-week range 99.33
News
globenewswire.com Tiziana KOL Call Highlights Consistency Between Positive Phase 2a INFORM-MS Topline Results and Longer-Term Clinical Benefits Observed in Expanded Access Program for Patients with Non-Active Secondary Progressive Multiple Sclerosis Treated with Intranasal Foralumab BOSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its…
globenewswire.com Elicio Therapeutics to Host Virtual KOL Event on November 11, 2026: ELI-002 7P for Metastatic and Neoadjuvant PDAC BOSTON, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for…
globenewswire.com Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026 MIAMI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation…
businesswire.com enGene to Host KOL Webinar on October 15, 2026 BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Therapeutics Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced that it will host a…
globenewswire.com vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes and the Cadisegliatin Phase 3 Program on October 20, 2026 HIGH POINT, N.C., Oct. 06, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigational therapy for type…
globenewswire.com Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026 NESS ZIONA, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today…
globenewswire.com Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026 FOSTER CITY, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional…
globenewswire.com Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026 SOUTH SAN FRANCISCO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease…
globenewswire.com Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference DALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and…
businesswire.com Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 AUSTIN, Texas--(BUSINESS WIRE)--Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today…
globenewswire.com Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program BOSTON and SAN DIEGO, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and…
globenewswire.com Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald Chairman and Chief Executive Officer, Roger M. Perlmutter, M.D., Ph.D., will participate in a key opinion leader (KOL) event on Thursday, August 20, 2026
globenewswire.com Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026 ALPHARETTA, Ga., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a company that focuses on developing first-in-class, new non-opioid…
globenewswire.com Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026 HOUSTON, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral,…
globenewswire.com Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday,…
prnewswire.com NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS" Featuring renowned ALS expert Prof. Jeremy Shefner, the discussion will address key unmet needs in ALS, trial endpoint design, and PrimeC's path forward CAMBRIDGE, Mass.
globenewswire.com OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026 BOULDER, Colo., July 02, 2026 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on developing novel precision medicines, today announced…
accessnewswire.com Cantargia and H.C. Wainwright to Host KOL Call on The Case for Nadunolimab in PDAC LUND, SE / ACCESS Newswire / June 11, 2026 / Cantargia AB (Publ) (STO:CANTA) today announced a KOL Call to be hosted in collaboration with H.C. Wainwright with leading subject matter experts Drs.
gurufocus.com TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer TriSalus Life Sciences, Inc. (Nasdaq: TLSI), an oncology company integrating novel delivery technology with standard-of-care therapies and an investigational i
businesswire.com TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI), an oncology company integrating novel delivery technology with standard-of-care therapies and an investigational…
benzinga.com These ETFs Should Enjoy Trump's Victory 
benzinga.com 3 Reasons To Be Bullish About The Recent Bearish News From China 
benzinga.com Will China's Economic Reforms Benefit BHP Billiton? - benzinga.com ETFs to Watch September 10, 2013 (BRF, IYF, UDN)
benzinga.com ETFs to Watch August 29, 2013 (EZA, FXF, SRS) - benzinga.com Three Materials ETFs Your Broker Forgot to Mention
benzinga.com ETFs To Watch August 12, 2013 (FAZ, HAO, XME) - benzinga.com ETFs to Watch July 24, 2013 (AMLP, EUO, JNK)
benzinga.com ETFs to Watch June 28, 2013 (BSV, DXJ, TUR) 
benzinga.com ETFs to Watch June 25, 2013 (BSV, DVY, FXC) 
benzinga.com ETFs to Watch June 14, 2013 (ELD, EPP, XLK) - benzinga.com ETFs to Watch May 9, 2013 (FXG, ILF, VUG)
- benzinga.com ETFs to Watch April 18, 2013 (DVY, LQD, RSX)
- benzinga.com ETFs to Watch April 12, 2013 (BSV, NUGT, THD)
- benzinga.com Materials Mess: These ETFs Are in Trouble
benzinga.com ETFs to Watch: March 8, 2013 (KOL, VUG, ITB) - benzinga.com ETFs to Watch January 3, 2013 (KOL, RSX, VTI)
- benzinga.com PowerShares to Shutter 13 ETFs
- benzinga.com 8 Sector ETFs for 2013
- benzinga.com The Final List of ETFs a Romney Win Could Benefit
- benzinga.com ETFs to Watch October 17, 2012 (FXF, SMH, XLK)
benzinga.com ETFs to Watch October 12, 2012 (FCG, KOL, TBT) - benzinga.com ETFs to Watch September 20, 2012 (KOL, PHB, SDY)
- benzinga.com ETFs to Watch September 10, 2012 (EWZ, KOL, TBT)
- benzinga.com ETFs to Watch August 13, 2012 (KOL, SDY, XLK)
- benzinga.com ETFs to Watch June 27, 2012 (BOND, EEV, SLV)
- benzinga.com ETFs to Watch May 11, 2012 (QID, FXP, UUP)
- benzinga.com ETFs to Watch March 16, 2012 (QLD, KOL, ECH)
- benzinga.com Resurgent Natural Gas? Try These ETFs (KOL, FCG, XOP)
- benzinga.com Slower Chinese Growth Could Plague These ETFs (FXI, EWZ, KOL)